Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Liang Zhang
Institution:
Amgen (United States)
Observed institution:
Amgen (United States)
ORCID:
0000-0001-5108-1638
Observed ORCID:
0000-0001-5108-1638
OpenAlex ID:
A5007796068
Development of a Commercial Manufacturing Process for Sotorasib, a First-in-Class KRAS G12C Inhibitor
2022
·
Liang Zhang
, Daniel J. Griffin
, et al.
·
Organic Process Research & Development
·
40
Kinetic and Mechanistic Investigations to Enable a Key Suzuki Coupling for Sotorasib Manufacture─What a Difference a Base Makes
2022
·
James I. Murray
, Liang Zhang
, et al.
·
Organic Process Research & Development
·
32
Developing and Optimizing a Quench-Crystallization Operation in Drug Substance Manufacturing
2023
·
Daniel J. Griffin
, Liang Zhang
, et al.
·
Organic Process Research & Development
·
3
Continuous-Flow Synthesis of the Key Nicergoline Intermediate 10α-Methoxy-9,10-dihydrolyserol via Photomethoxylation
2026
·
Renfu Huang
, Jun Yu
, et al.
·
Organic Process Research & Development
Show more works
View as search
Works count:
4
Citation count:
75
H-index:
3
I10-index:
2
Year
Topic
Type